← All trials
NCT06134375
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 31, 2024
- Primary completion
- Mar 31, 2029
- Completion date
- Mar 31, 2034
- First posted
- Nov 18, 2023
- Last posted
- Dec 5, 2023
- Enrollment
- 204
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Dartmouth UniversityLead sponsor
- Dartmouth UniversityReponsible party - principal investigator
- Dartmouth UniversitySponsor investigator
- Department of DefenseCollaborator
- National Cancer Institute (NCI)Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.